QT
EDIT icon

Quantbot Technologies’s Editas Medicine EDIT Stock Holding History

Quantbot Technologies’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17
Closed -$42 – 1999
2026
Q1 		$42 Buy
+17
New +$36 ﹤0.01% 1641
2024
Q2 		– Sell
-400
Closed -$2.97K – 1569
2024
Q1 		$2.97K Sell
400
-14,000
-97% -$116K ﹤0.01% 1493
2023
Q4 		$146K Buy
+14,400
New +$126K 0.01% 1093
2023
Q2 		– Sell
-17,106
Closed -$124K – 1672
2023
Q1 		$124K Buy
+17,106
New +$152K 0.01% 1031
2022
Q4 		– Sell
-14,636
Closed -$179K – 1772
2022
Q3 		$179K Buy
+14,636
New +$228K 0.01% 922
2022
Q2 		– Sell
-2,353
Closed -$44K – 1803
2022
Q1 		$44K Buy
+2,353
New +$43.7K ﹤0.01% 1224
2021
Q2 		– Sell
-7,928
Closed -$332K – 1542
2021
Q1 		$332K Buy
7,928
+7,748
+4,304% +$441K 0.03% 601
2020
Q4 		$12K Buy
+180
New +$7.39K ﹤0.01% 1080
2020
Q3 		– Sell
-164
Closed -$4K – 1376
2020
Q2 		$4K Buy
+164
New +$4.29K ﹤0.01% 1028
2020
Q1 		– Sell
-3,700
Closed -$109K – 1026
2019
Q4 		$109K Buy
3,700
+3,000
+429% +$74.9K 0.01% 801
2019
Q3 		$15K Buy
+700
New +$17.3K ﹤0.01% 1136
2018
Q3 		– Sell
-7,335
Closed -$262K – 1318
2018
Q2 		$262K Buy
7,335
+5,356
+271% +$190K 0.02% 695
2018
Q1 		$65K Buy
+1,979
New +$70.5K 0.01% 939
2017
Q4 		– Sell
-4,947
Closed -$118K – 1261
2017
Q3 		$118K Buy
4,947
+1,077
+28% +$20.5K 0.01% 810
2017
Q2 		$64K Sell
3,870
-276
-7% -$4.97K 0.01% 877
2017
Q1 		$92K Buy
+4,146
New +$85.9K 0.01% 805

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Quantbot Technologies's EDIT Position: Q2 2026 in Review

Quantbot Technologies sold out of Editas Medicine (EDIT) in Q2 2026, closing a stake of 17 shares — an estimated $42 sold.

Quantbot Technologies first reported a position in EDIT in Q1 2017 and held it in 16 quarters. The position peaked at $332K in Q1 2021. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Quantbot Technologies reported no remaining Editas Medicine position as of Q2 2026 after selling out during the quarter.
  • Quantbot Technologies sold 17 Editas Medicine shares in Q2 2026, an estimated $42.
  • Quantbot Technologies first reported a position in Editas Medicine in Q1 2017 and held it in 16 quarters.
  • Quantbot Technologies's Editas Medicine position peaked at $332K in Q1 2021.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.